# Managing Type 1 and High Risk Type 2 Diabetes in the Hospital Setting: Glucose as a Vital Sign

Study · id `cardio:ct-nct03068273` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03068273](<https://clinicaltrials.gov/study/NCT03068273>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03068273

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 157 participants.

## Technical summary

Registry record NCT03068273. Randomized; single masking; primary purpose other. Start 2015-05 (actual); primary completion 2020-03-17 (actual). Results posted on 2025-10-15.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose other
- Phase: Not applicable
- Enrolled: 157 participants (enrolled count; ClinicalTrials.gov record NCT03068273, source copy `cardio:ctgov-nct03068273-2025-10-15`, retrieved 2026-10-26)
- Started: 2015-05 (actual) (ClinicalTrials.gov record NCT03068273, source copy `cardio:ctgov-nct03068273-2025-10-15`, retrieved 2026-10-26)
- Primary completion: 2020-03-17 (actual) (ClinicalTrials.gov record NCT03068273, source copy `cardio:ctgov-nct03068273-2025-10-15`, retrieved 2026-10-26)
- Completion: 2020-03-17 (actual) (ClinicalTrials.gov record NCT03068273, source copy `cardio:ctgov-nct03068273-2025-10-15`, retrieved 2026-10-26)
- Results first posted: 2025-10-15 (ClinicalTrials.gov record NCT03068273, source copy `cardio:ctgov-nct03068273-2025-10-15`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03068273, source copy `cardio:ctgov-nct03068273-2025-10-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03068273-2025-10-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Managing Type 1 and High Risk Type 2 Diabetes in the Hospital Setting: Glucose as a Vital Sign
- Acronym: CGM
- Condition: Diabetes Mellitus, Type 1
- Condition: Diabetes Mellitus, Type 2
- Intervention (Device): Real-time CGM data
- Lead sponsor: Scripps Whittier Diabetes Institute
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Scripps Whittier Diabetes Institute (`cardio:org-scripps-whittier-diabetes-institute`)

## Provenance

Content hash: 1ff09f67609a332bc8930b31608573a82e093c0302cbd48a32cf4332a13695e7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
